BRPI0416807A - sistemas de expressão aperfeiçoados com secreção de sistema sec - Google Patents

sistemas de expressão aperfeiçoados com secreção de sistema sec

Info

Publication number
BRPI0416807A
BRPI0416807A BRPI0416807-0A BRPI0416807A BRPI0416807A BR PI0416807 A BRPI0416807 A BR PI0416807A BR PI0416807 A BRPI0416807 A BR PI0416807A BR PI0416807 A BRPI0416807 A BR PI0416807A
Authority
BR
Brazil
Prior art keywords
sec
secretion
expression systems
systems
sec system
Prior art date
Application number
BRPI0416807-0A
Other languages
English (en)
Inventor
Diane M Retallack
Jane C Schneider
Thomas Martin Ramseier
Original Assignee
Dow Global Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Inc filed Critical Dow Global Technologies Inc
Publication of BRPI0416807A publication Critical patent/BRPI0416807A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"SISTEMAS DE EXPRESSãO APERFEIçOADOS COM SECREçãO DE SISTEMA SEC". Métodos e sistemas de expressão procarióticos aperfeiçoados para produção de proteínas recombinantes usando peptídeos de sinal de secreção de sistema Sec são descritos usando sistemas de secreção de Sec de Pseudomonas fluorescens. Peptídeos de sinal de secreção de sistema Sec novos específicos são descritos, como o são proteínas de fusão e seqüências de codificação para secreção aperfeiçoada de proteínas e peptídeos recombinantes.
BRPI0416807-0A 2003-11-21 2004-11-22 sistemas de expressão aperfeiçoados com secreção de sistema sec BRPI0416807A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52412403P 2003-11-21 2003-11-21
PCT/US2004/039316 WO2005089093A2 (en) 2003-11-21 2004-11-22 Improved expression systems with sec-system secretion

Publications (1)

Publication Number Publication Date
BRPI0416807A true BRPI0416807A (pt) 2007-01-09

Family

ID=34994140

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416807-0A BRPI0416807A (pt) 2003-11-21 2004-11-22 sistemas de expressão aperfeiçoados com secreção de sistema sec

Country Status (11)

Country Link
US (1) US7985564B2 (pt)
EP (4) EP2336153B1 (pt)
JP (1) JP5028551B2 (pt)
KR (1) KR101265343B1 (pt)
CN (1) CN1882605B (pt)
AU (1) AU2004317306B2 (pt)
BR (1) BRPI0416807A (pt)
CA (1) CA2546157C (pt)
MX (1) MXPA06005705A (pt)
PL (2) PL2336153T3 (pt)
WO (1) WO2005089093A2 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
JP5028551B2 (ja) 2003-11-21 2012-09-19 フェネックス インコーポレイテッド Ｓｅｃ系分泌によって改良された発現系
WO2006014899A2 (en) 2004-07-26 2006-02-09 Dow Global Technologies Inc. Process for improved protein expression by strain engineering
JP5130662B2 (ja) * 2006-06-07 2013-01-30 Ｊｎｃ株式会社 タンパク質の可溶性タンパク質としての製造方法
AU2008210538B2 (en) * 2007-01-31 2013-06-06 Pelican Technology Holdings, Inc. Bacterial leader sequences for increased expression
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
WO2009076196A1 (en) 2007-12-07 2009-06-18 Dow Global Technologies Inc. High copy number self-replicating plasmids in pseudomonas
WO2010008764A1 (en) * 2008-06-23 2010-01-21 Dow Global Technologies Inc. Pseudomonas fluorescens strains for production of extracellular recombinant protein
UA106885C2 (uk) 2009-04-17 2014-10-27 Дау Агросайансіз Елелсі Dig-3 інсектицидні cry-токсини
JP2013514769A (ja) 2009-12-16 2013-05-02 ダウ アグロサイエンシィズ エルエルシー 害虫抵抗性管理のためのＣＲＹ１ＣａおよびＣＲＹ１Ｆａタンパク質の併用
ES2639398T3 (es) 2010-03-04 2017-10-26 Pfenex Inc. Método para producir proteína de interferón recombinante soluble sin desnaturalización
EP2553102B1 (en) 2010-03-30 2015-12-09 Pfenex Inc. High level expression of recombinant toxin proteins
CA2794740C (en) 2010-04-01 2019-12-31 Pfenex Inc. Methods for g-csf production in a pseudomonas host cell
RU2582249C2 (ru) 2010-04-23 2016-04-20 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи КОМБИНАЦИИ, ВКЛЮЧАЮЩИЕ БЕЛКИ Cry34Ab/35Ab И Cry3Aa, ДЛЯ ПРЕДОТВРАЩЕНИЯ РАЗВИТИЯ УСТОЙЧИВОСТИ У КУКУРУЗНЫХ КОРНЕВЫХ ЖУКОВ (Diabrotica spp.)
US9234208B1 (en) 2010-05-10 2016-01-12 Dow Agrosciences Llc DIG-13 insecticidal cry toxins
AR084293A1 (es) 2010-12-16 2013-05-08 Dow Agrosciences Llc Cry1FA RADIOMARCADA, BIOLOGICAMENTE ACTIVA Y METODOS DE ENSAYOS DE UNION AL RECEPTOR
JP6362543B2 (ja) 2012-02-23 2018-07-25 ジュノ セラピューティクス ゲーエムベーハー 細胞および他の複雑な生物学的材料のクロマトグラフィーによる単離
EP2841590A4 (en) * 2012-04-27 2016-03-23 Pronutria Inc NUCLEIC ACIDS, CELLS AND METHODS FOR PRODUCING SECRETED PROTEINS
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
CN103254277B (zh) * 2013-05-03 2017-02-08 南京工业大学 强分泌性信号肽增强小肽模序及其应用
AR099800A1 (es) 2014-03-21 2016-08-17 Agrigenetics Inc Cry1d para controlar el gusano de la mazorca del maíz
NZ726117A (en) 2014-06-20 2017-10-27 Dow Agrosciences Llc Vegetative insecticidal proteins useful for control of insect pests
EP3227455B1 (en) 2014-12-01 2023-07-12 Pfenex Inc. Fusion partners for peptide production
MX2017008413A (es) 2014-12-30 2017-10-19 Dow Agrosciences Llc Toxinas cry1ca modificadas utiles para el control de plagas de insectos.
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
CA3038972A1 (en) 2016-09-30 2018-04-05 Dow Agrosciences Llc Binary insecticidal cry toxins
AR111625A1 (es) 2017-04-27 2019-07-31 Juno Therapeutics Gmbh Reactivos de partículas oligoméricas y métodos de uso de los mismos
CA3077393A1 (en) * 2017-10-27 2019-05-02 Pfenex Inc. Bacterial leader sequences for periplasmic protein expression
CN111278852B (zh) 2017-10-27 2024-07-16 菲尼克斯公司 重组欧氏杆菌天冬酰胺酶的生产方法
CN110819647A (zh) * 2018-08-07 2020-02-21 康码（上海）生物科技有限公司 信号肽相关序列及其在蛋白质合成中的应用
CN112812176B (zh) * 2021-01-13 2022-10-11 江南大学 一种通过低盐絮凝法从螺旋藻中提取藻蓝蛋白的方法
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4595658A (en) 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4513600A (en) 1983-01-03 1985-04-30 The Minster Machine Company Cam actuated ejector for a shell press
GB8308483D0 (en) 1983-03-28 1983-05-05 Health Lab Service Board Secretion of gene products
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US4680264A (en) 1983-07-01 1987-07-14 Lubrizol Genetics, Inc. Class II mobilizable gram-negative plasmid
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
US4637980A (en) 1983-08-09 1987-01-20 Smithkline Beckman Corporation Externalization of products of bacteria
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
EP0155189A3 (en) 1984-03-16 1987-09-16 Genentech, Inc. Expression of cell wall degrading proteins and host cells harboring dna encoding such protein
US4963495A (en) 1984-10-05 1990-10-16 Genentech, Inc. Secretion of heterologous proteins
DE3586386T2 (de) 1984-10-05 1993-01-14 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
GB8529014D0 (en) 1985-11-25 1986-01-02 Biogen Nv Enhanced secretion of heterologous proteins
US5232840A (en) 1986-03-27 1993-08-03 Monsanto Company Enhanced protein production in bacteria by employing a novel ribosome binding site
DE3850995T2 (de) 1987-04-23 1995-03-16 Monsanto Co Sekretion eines dem Insulin ähnlichen Wachstumsfaktors in E. coli.
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
EP0422049A4 (en) 1988-05-09 1991-11-13 Us Health Vector for secretion of proteins directly into periplasm or culture medium
US5169772A (en) 1988-06-06 1992-12-08 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase from flavobacterium heparinum
US6780613B1 (en) 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
US5175099A (en) 1989-05-17 1992-12-29 Research Corporation Technologies, Inc. Retrovirus-mediated secretion of recombinant products
US5169760A (en) 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
US5641671A (en) 1990-07-06 1997-06-24 Unilever Patent Holdings B.V. Production of active Pseudomonas glumae lipase in homologous or heterologous hosts
FI913434A (fi) 1990-07-16 1992-01-17 Technical Research Centre F Finland Rekombinanta fusionsproteiner vilka utsoendras.
US5417971A (en) 1991-10-22 1995-05-23 University Of Saskatchewan Vaccines for Actinobacillus pleuropneumoniae
US5348867A (en) 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
US5914254A (en) 1993-08-02 1999-06-22 Celtrix Pharmaceuticals, Inc. Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
US5563046A (en) 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
US5527883A (en) 1994-05-06 1996-06-18 Mycogen Corporation Delta-endotoxin expression in pseudomonas fluorescens
DE69532646T2 (de) 1994-12-09 2005-03-03 Novo Nordisk A/S Verfahren zur herstellung extrazellulärer proteine in bakterien
US6495357B1 (en) 1995-07-14 2002-12-17 Novozyme A/S Lipolytic enzymes
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
DE69731210T2 (de) * 1996-08-16 2005-10-20 Genencor International, Inc., Palo Alto Expressionssystem abgeleitet von der lipase-regulationskaskade von pseudonomas alcaligenes
US6361989B1 (en) 1997-10-13 2002-03-26 Novozymes A/S α-amylase and α-amylase variants
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
US6156552A (en) 1998-02-18 2000-12-05 Novo Nordisk A/S Lipase variants
US20030064435A1 (en) 1998-05-28 2003-04-03 Weiner Joel Hirsch Compositions and methods for protein secretion
US6323007B1 (en) 1998-09-18 2001-11-27 Novozymes A/S 2,6-β-D-fructan hydrolase enzyme and processes for using the enzyme
IL142269A0 (en) 1998-10-28 2002-03-10 Genentech Inc Process for recovering heterologous polypetides from bacterial cells
KR100312456B1 (ko) 1999-03-13 2001-11-03 윤덕용 슈도모나스 플루오레슨스 유래의 외래단백질 분비촉진유전자
KR100716042B1 (ko) 1999-03-29 2007-05-08 노보자임스 에이/에스 분지 효소 활성을 가지는 폴리펩티드 및 그것을코드화하는 핵산
US6664386B1 (en) 1999-04-08 2003-12-16 The Research Foundation Of State University Of New York System for efficient secretion of recombinant proteins
US6558939B1 (en) 1999-08-31 2003-05-06 Novozymes, A/S Proteases and variants thereof
DE19944870A1 (de) 1999-09-18 2001-03-29 Aventis Pharma Gmbh Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
US6617143B1 (en) 1999-10-20 2003-09-09 Novozymes A/S Polypeptides having glucanotransferase activity and nucleic acids encoding same
US6509181B1 (en) 2000-04-14 2003-01-21 Novozymes, A/S Polypeptides having haloperoxide activity
US7087412B2 (en) 2000-11-14 2006-08-08 Boehringer Ingelheim International Gmbh Methods for large scale protein production in prokaryotes
GB0027782D0 (en) 2000-11-14 2000-12-27 Boehringer Ingelheim Int Methods fro large scale protein productio in prokaryotes
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
DE10108212A1 (de) 2001-02-20 2002-08-22 Aventis Pharma Gmbh Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände
US7419783B2 (en) 2001-11-05 2008-09-02 Research Development Foundation Engineering of leader peptides for the secretion of recombinant proteins in bacteria
MXPA04007886A (es) 2002-02-13 2004-10-15 Dow Global Technologies Inc Sobre-expresion de genes de extremozimo en pseudomonadas y bacterias estrechamente relacionadas.
WO2003079007A1 (en) 2002-03-15 2003-09-25 The Trustees Of The University Of Pennsylvania Heterologous protein production using the twin arginine translocation pathway
CN100489114C (zh) 2002-04-22 2009-05-20 陶氏环球技术公司 低成本生产肽
JP2006506049A (ja) 2002-07-03 2006-02-23 ダウ グローバル テクノロジーズ インコーポレイティド ベンゾエート−及びアントラニレート−誘導性プロモーター
JP5028551B2 (ja) 2003-11-21 2012-09-19 フェネックス インコーポレイテッド Ｓｅｃ系分泌によって改良された発現系
PL1709170T3 (pl) * 2004-01-16 2018-06-29 Pfenex Inc. Ekspresja białek ssaczych w Pseudomonas fluorescens
AU2008210538B2 (en) 2007-01-31 2013-06-06 Pelican Technology Holdings, Inc. Bacterial leader sequences for increased expression

Also Published As

Publication number Publication date
WO2005089093A3 (en) 2006-03-02
MXPA06005705A (es) 2006-08-23
PL2327718T3 (pl) 2016-10-31
EP1687324B1 (en) 2012-08-22
PL2336153T3 (pl) 2016-08-31
JP5028551B2 (ja) 2012-09-19
KR101265343B1 (ko) 2013-05-20
CA2546157A1 (en) 2005-09-29
EP2314602A1 (en) 2011-04-27
AU2004317306B2 (en) 2010-09-02
EP2327718B1 (en) 2016-03-23
AU2004317306A1 (en) 2005-09-29
JP2007512028A (ja) 2007-05-17
EP1687324A2 (en) 2006-08-09
EP2336153B1 (en) 2016-03-30
EP2336153A1 (en) 2011-06-22
US7985564B2 (en) 2011-07-26
KR20060123173A (ko) 2006-12-01
EP2327718A1 (en) 2011-06-01
CA2546157C (en) 2014-07-22
CN1882605A (zh) 2006-12-20
EP1687324A4 (en) 2007-08-22
WO2005089093A2 (en) 2005-09-29
US20060008877A1 (en) 2006-01-12
CN1882605B (zh) 2012-07-11

Similar Documents

Publication Publication Date Title
BRPI0416807A (pt) sistemas de expressão aperfeiçoados com secreção de sistema sec
DE60235039D1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
BR0207394A (pt) Proteìna de fusão para a secreção de uma proteìna de interesse no sobrenadante da cultura bacteriana
DE69637844D1 (de) Neues tgf-beta-ahnliches cytokin
DK1594971T3 (da) Transposonbaseret målretningssystem
DE69125381D1 (de) Proteinstruktur des pflanzlichen toxins gelonin
DE60118359D1 (de) Humanische pellino-polypeptide
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
DE69120390D1 (de) Kollagen-bindendes protein sowie dessen herstellung
WO2000058465A3 (en) Flint polypeptide analogs
WO2006035311A3 (en) Group a streptococcus crge protein
DK0826054T3 (da) Ekspression af glycosyltransferase i Aspergillus
DE602005016417D1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
DE69935213D1 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
TR200003345T2 (tr) Moraxella Catarrhalıs'in bileşikleri
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
DE69933444D1 (de) Proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
DE602004004796D1 (de) Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide
ATE420962T1 (de) Rekombinante n-proteinase, deren herstellung, methoden und anwendungen
SE0101519D0 (sv) Nucleic ACID
ATE412753T1 (de) Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür
DE60039303D1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
EP0906957A3 (en) Lgt polypeptide
WO2005047320A3 (en) Equine p-selection glycoprotein ligand-1 and uses thereof

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 7A ANUIDADE.